Breast Cancer Screening Guidelines for Women

U.S. Preventive American Cancer American College International American College American College American
Services Task Society2 of Obstetricians Agency for of Radiology5 of Physicians6 Academy of
Force1 2015 and Research on 2010 Family
2016 Gynecologists3 Cancer4 Physicians7
2011 2015 2016
Women aged The decision to Women aged 40 to Screening with Insufficient Screening with Discuss benefits The decision to
40 to 49 with start screening 44 years should mammography and evidence to mammography and harms with start screening
average risk mammography in have the choice to clinical breast recommend for or annually. women in good mammography
women prior to age start annual breast exams annually. against screening. health and order should be an
50 years should be cancer screening screening with individual one.
an individual one. with mammograms mammography Women who place
Women who place if they wish to do every two years if a a higher value on
a higher value on so. The risks of woman requests it. the potential
the potential screening as well benefit than the
benefit than the as the potential potential harms
potential harms benefits should be may choose to
may choose to considered. begin screening.
begin biennial
screening between Women aged 45 to
the ages of 40 and 49 years should
49 years. get mammograms
every year.
Women aged Biennial screening Women aged 50 to Screening with For women aged Screening with Physicians should Biennial screening
50 to 74 with mammography is 54 years should mammography and 50 to 69 years, mammography encourage with
average risk recommended. get mammograms clinical breast screening with annually. mammography mammography.
every year. exam annually. mammography is screening every
recommended. two years in
Women aged 55 average-risk
years and older For women aged women.
should switch to 70 to 74 years,
mammograms evidence suggests
every 2 years, or that screening with
have the choice to mammography
continue yearly substantially
screening. reduces the risk of
death from breast
cancer, but it is not
currently
recommended.
 U.S. Preventive American Cancer American College International American College American College American
Services Task Society2 of Obstetricians Agency for of Radiology5 of Physicians6 Academy of
Force1 2015 and Research on 2010 Family
2016 Gynecologists3 Cancer4 Physicians7
2011 2015 2016
Women aged Current evidence is Screening should Women should, in Not addressed. Screening with Screening is not Current evidence is
75 or older insufficient to continue as long as consultation with mammography recommended. insufficient to
with average assess the balance a woman is in good their physicians, should stop when assess the balance
risk of benefits and health and is decide whether or life expectancy is of benefits and
harms of screening expected to live 10 not to continue less than 5 to 7 harms of screening
mammography in more years or mammographic years on the basis with
women aged 75 longer. screening. of age or comorbid mammography.
years or older. conditions.
Women with Current evidence is There is not Insufficient Insufficient In addition to Not addressed. Current evidence is
dense breasts insufficient to enough evidence evidence to evidence to mammography, insufficient to
assess the balance to make a recommend for or recommend for or ultrasound can be assess the balance
of benefits and recommendation against MRI against screening. considered. of benefits and
harms of adjunctive for or against screening. harms of adjunctive
screening for yearly MRI screening for
breast cancer screening. breast cancer
using breast using breast
ultrasonography, ultrasonography,
magnetic MRI, DBT, or other
resonance imaging methods.
(MRI), digital
breast
tomosynthesis
(DBT), or other
methods in women
identified to have
dense breasts on
an otherwise
negative screening
mammogram.
 U.S. Preventive American Cancer American College International American College American College American
Services Task Society2 of Obstetricians Agency for of Radiology5 of Physicians6 Academy of
Force1 2015 and Research on 2010 Family
2016 Gynecologists3 Cancer4 Physicians7
2011 2015 2016
Women at Women with a Women who are at For women who Evidence suggests For BRCA1 or Not addressed. Not addressed.
higher than parent, sibling, or high risk for breast test positive for that screening BRCA2 mutation
average risk child with breast cancer based on BRCA1 or BRCA2 (mammography carriers, untested
cancer are at certain factors mutations or have and MRI) at an family members of
higher risk for (such as having a a lifetime risk of earlier age may be BRCA1 or BRCA2
breast cancer and parent, sibling, or 20% or greater, beneficial. mutation carriers,
thus may benefit child with a BRCA screening should and women with a
more than 1 or BRCA2 gene include twice- lifetime risk of 20%
average-risk mutation) should yearly clinical or greater (based
women from get an MRI and a breast exams, on family history),
beginning mammogram every annual screening should
screening in their year. mammography, include annual
40s. annual breast MRI, mammography and
and breast self- annual MRI starting
exams. by age 30 years
but not before age
For women who 25 years.
received thoracic
irradiation between For women with a
ages 10 and 30 history of chest
years, screening irradiation between
should include the ages of 10 and
annual 30 years, annual
mammography, mammography and
annual MRI, and annual MRI starting
screening clinical 8 years after
breast exams treatment
every 6 to 12 (mammography not
months beginning recommended
8 to 10 years after before age 25).
radiation treatment
or at age 25 years.
 U.S. Preventive American Cancer American College International American College American College American
Services Task Society2 of Obstetricians Agency for of Radiology5 of Physicians6 Academy of
Force1 2015 and Research on 2010 Family
2016 Gynecologists3 Cancer4 Physicians7
2011 2015 2016
Additional Current evidence is Women should be Not addressed. Not addressed. Not addressed. Annual Recommends
issues insufficient to familiar with the mammography, against clinicians
relevant for all assess the benefits known benefits, MRI, teaching women
women and harms of limitations, and tomosynthesis, or breast self-exams.
digital breast potential harms regular systematic Current evidence is
tomosynthesis associated with breast self-exam insufficient to
(DBT) as a primary breast cancer are not assess the benefits
screening method screening. They recommended. and harms of
for breast cancer. should also be clinical breast
familiar with how exams and DBT.
their breasts
normally look and
feel and report any
changes to a
health care
provider right
away.

1SiuAL; U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal
Medicine 2016;164(4):279296.
2Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent
J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R; American Cancer Society. Breast cancer screening for women at average
risk: 2015 guideline update from the American Cancer Society. JAMA 2015;314(15):15991614.
3American College of Obstetricians-Gynecologists. Practice bulletin no. 122: Breast cancer screening. Obstetrics and Gynecology 2011;118(2 Pt 1):372382.
4Lauby-Secretan B, Loomis D, Straif K. Breast-cancer screeningviewpoint of the IARC Working Group. New England Journal of Medicine 2015;373(15):1478
1479.
5Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, DOrsi C, Sickles E,
Burhenne LW. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast
MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. Journal of the American College of Radiology 2010;7(1):1827.
6Wilt
TJ, Harris RP, Qaseem A; High Value Care Task Force of the American College of Physicians. Screening for cancer: advice for high-value care from the
American College of Physicians. Annals of Internal Medicine 2015;162(10):718725.
7American Academy of Family Physicians. Summary of recommendations for clinical preventive services. 2016. Available from:
http://www.aafp.org/dam/AAFP/documents/patient_care/clinical_recommendations/cps-recommendations.pdf [PDF-574KB].